Skip to content

A study comparing steroid mouth treatment with and without low-level laser therapy for pain relief and healing in patients with symptomatic Oral Lichen Planus

Comparative efficacy of topical corticosteroids with and without low level laser therapy in the management of patients with symptomatic oral lichen planus: A double blind randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109220
Enrollment
54
Registered
2026-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L438- Other lichen planus

Interventions

Intervention1: Group A (Test group): Patients receiving Low-Level Laser Therapy (LLLT) applied over topical corticosteroids. : In this group following parameters are assessed at baseline (day 0), tre

Sponsors

State Board of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years and above, clinically and histologically diagnosed with Oral Lichen Planus, presenting with symptoms such as pain and/or burning sensation, shall be included in the study

Exclusion criteria

Exclusion criteria: 1.Current systemic steroid or immunosuppressive therapy for OLP 2.Pregnancy or lactation 3.Presence of any other oral mucosal lesions 4.Patients with diseases like chronic debilitating diseases like renal disease, CVA and CAD

Design outcomes

Primary

MeasureTime frame
The outcome of the study will be assessed using subjective symptom assessment and objective clinical recovery assessment: Assessment of Symptoms: Subjective symptoms, including pain and burning sensation, will be assessed using the Visual Analog Scale (VAS). Assessment of Clinical Recovery: Clinical recovery of Oral Lichen Planus lesions will be evaluated using the Piboonniyom et al. (2005) scoring systemTimepoint: Outcome assessed at baseline (day 0), treatment phase (7, 14, 21 and 28 days) and follow up period (45, 60,75 and 90 days)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR NIKHITHA V

GOVT DENTAL COLLEGE CALICUT

psharis@rediffmail.com9447302771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026